Veverimer clinical trials
Also written TRC101.
How each study uses veverimer is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the veverimer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test veverimer, phase 3 first.
- Jun 2027A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic AcidosisPhase 3 · Renibus Therapeutics, Inc.
Studies
Open first, then newest update. How each study uses veverimer is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic AcidosisRecruitingPhase 3Renibus Therapeutics, Inc.NCT07355062Written as Veverimer
- Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic AcidosisTerminatedPhase 3Tricida, Inc.NCT03710291Written as TRC101
- Long-term Safety Extension to Study TRCA-301CompletedPhase 3Tricida, Inc.NCT03390842Written as TRC101
- Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney DiseaseCompletedPhase 3Tricida, Inc.NCT03317444Written as TRC101
- Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic AcidosisCompletedPhase 1/2Tricida, Inc.NCT02809183Written as TRC101
Codes
What other systems call veverimer · ClinicalTrials.gg INT001091
- UNII (FDA) 10VSMQY402VEVERIMEROne source FDA
- NCI Thesaurus C171662VeverimerOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 10VSMQY402 | VEVERIMER | One source FDA |
| NCI Thesaurus | C171662 | Veverimer | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.